Welcome to the January 2018 issue of the Journal of Clinical and Aesthetic Dermatology (JCAD). We start this issue with a study titled “Chronic Skin Fragility of Aging: Current Concepts in the Pathogenesis, Recognition, and Management of Dermatoporosis.” In this review, Dyer and Miller explore the risk factors, pathogenetic mechanisms, clinical expression, and evidence-based therapies reported for chronic skin fragility due to aging. Termed dermatoporosis, the authors discuss diagnosis, prevention, and therapeutic options for managing the condition.
Next, Wang et al present their review of new-onset dermatitis in patients aged 60 years or older. Here, the authors examine differences between patients with dermatitis of immune senescence and those who were ultimately given more specific diagnoses. Ultimately, the authors did not find significant differences between demographics, affected body surface area, laboratory workup, or mortality between patients with dermatitis of immune senescence and those patients with more specific diagnoses.
Following this, in the article titled “Adult Acne versus Adolescent Acne: A Retrospective Study of 1,167 Patients,” Skroza et al provide results from a study that evaluated differences between adults and teenagers with regard to acne, including prevalence, patient sex, severity, and impact on quality of life. Skroza and colleagues report that acne in female patients was more prevalent than in male patients, with “mild acne” being most prevalent among all study subjects. With regard to family history of acne, time of onset, and smoking habits, the authors did not find any statistically significant differences between the sexes. However, it appears that quality of life is more negatively affected in women with acne compared to men.
Next, Barak-Shinar and Green present their study titled “Scalp Seborrheic Dermatitis and Dandruff Therapy Using a Herbal and Zinc Pyrithione-based Therapy of Shampoo and Scalp Lotion.” The authors evaluated the safety and efficacy of an herbal and zinc pyrithione shampoo and a scalp lotion for the treatment of scalp seborrheic dermatitis and dandruff. The authors found a reduction in erythema and flaking in subjects with moderate-or-greater seborrheic dermatitis at all time points over the course of 42 days after using the study shampoo and scalp lotion.
After this, in their article titled “Granuloma Annulare and Radial Pulse Therapy: Preliminary Findings,” Mickel et al describe a first-time trial of a variation of extracorporeal shockwave therapy for the treatment of a case of disseminated granuloma annulare. Radial pulse therapy was administered in a university hospital’s outpatient clinic to a 72-year-old woman with a 14-year history of disseminated granuloma annulare. The authors describe changes in clinical appearance and results of histological evaluation, reporting observable positive changes in all four treated areas.
And finally, in their article titled “Patient Knowledge of Sunscreen Guidelines and Frequency of Physician Counseling: A Cross-sectional Study,” Vasicek et al investigate patient knowledge of the American Academy of Dermatology guidelines for proper sunscreen use and patient-reported rates of physician counseling regarding sunscreen. The authors found that a majority of the participants understood the recommended frequency of proper sunscreen use and the recommended minimum sun protection factor (59% and 60%, respectively). However, the minimum amount of sunscreen to cover the body, time of application before sun exposure, and time between reapplications of sunscreen did not receive a majority response, and the authors recommend more frequent and in-depth sunscreen counseling for patients by their dermatologists and primary care physicians.
We hope you enjoy this issue of JCAD. As always, we welcome your feedback and submissions.
James Q. Del Rosso, DO, FAOCD
Editor-in-Chief, Clinical Dermatology
Wm. Philip Werschler, MD, FAAD, FAACS
Editor-in-Chief, Aesthetic Dermatology
Seemal R. Desai, MD, FAAD